Ingelvac PCV FLEX

RSS

Withdrawn

This medicine's authorisation has been withdrawn

porcine circovirus vaccine (inactivated)
MedicineVeterinaryWithdrawn

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn at the request of the marketing authorisation holder.

български (BG) (302.02 KB - PDF)

Skoða

español (ES) (354.71 KB - PDF)

Skoða

čeština (CS) (398.51 KB - PDF)

Skoða

dansk (DA) (353.81 KB - PDF)

Skoða

Deutsch (DE) (356.65 KB - PDF)

Skoða

eesti (ET) (353.06 KB - PDF)

Skoða

ελληνικά (EL) (422.14 KB - PDF)

Skoða

français (FR) (356.76 KB - PDF)

Skoða

hrvatski (HR) (377.01 KB - PDF)

Skoða

italiano (IT) (353.82 KB - PDF)

Skoða

latviešu (LV) (406.74 KB - PDF)

Skoða

lietuvių (LT) (379.26 KB - PDF)

Skoða

magyar (HU) (396.03 KB - PDF)

Skoða

Malti (MT) (409.42 KB - PDF)

Skoða

Nederlands (NL) (354.93 KB - PDF)

Skoða

polski (PL) (399.96 KB - PDF)

Skoða

português (PT) (355.88 KB - PDF)

Skoða

română (RO) (378.84 KB - PDF)

Skoða

slovenčina (SK) (399.95 KB - PDF)

Skoða

slovenščina (SL) (388.87 KB - PDF)

Skoða

suomi (FI) (352.89 KB - PDF)

Skoða

svenska (SV) (354.63 KB - PDF)

Skoða

Product information

български (BG) (711.12 KB - PDF)

Skoða

español (ES) (810.61 KB - PDF)

Skoða

čeština (CS) (932.35 KB - PDF)

Skoða

dansk (DA) (807.39 KB - PDF)

Skoða

Deutsch (DE) (801.97 KB - PDF)

Skoða

eesti (ET) (803.1 KB - PDF)

Skoða

ελληνικά (EL) (1.13 MB - PDF)

Skoða

français (FR) (922.81 KB - PDF)

Skoða

hrvatski (HR) (822.66 KB - PDF)

Skoða

italiano (IT) (806.79 KB - PDF)

Skoða

latviešu (LV) (957.91 KB - PDF)

Skoða

lietuvių (LT) (826.73 KB - PDF)

Skoða

magyar (HU) (938.04 KB - PDF)

Skoða

Malti (MT) (965.75 KB - PDF)

Skoða

Nederlands (NL) (902.64 KB - PDF)

Skoða

polski (PL) (926.02 KB - PDF)

Skoða

português (PT) (810.56 KB - PDF)

Skoða

română (RO) (837.75 KB - PDF)

Skoða

slovenčina (SK) (936.99 KB - PDF)

Skoða

slovenščina (SL) (973.11 KB - PDF)

Skoða

suomi (FI) (837.29 KB - PDF)

Skoða

svenska (SV) (805.16 KB - PDF)

Skoða

Íslenska (IS) (810.01 KB - PDF)

Skoða

norsk (NO) (808.14 KB - PDF)

Skoða
Latest procedure affecting product information:IG/0855/G
24/11/2017

български (BG) (336.55 KB - PDF)

Skoða

español (ES) (278.67 KB - PDF)

Skoða

čeština (CS) (308.83 KB - PDF)

Skoða

dansk (DA) (281.18 KB - PDF)

Skoða

Deutsch (DE) (281.33 KB - PDF)

Skoða

eesti (ET) (279.45 KB - PDF)

Skoða

ελληνικά (EL) (312.94 KB - PDF)

Skoða

français (FR) (278.12 KB - PDF)

Skoða

hrvatski (HR) (296.78 KB - PDF)

Skoða

italiano (IT) (277.07 KB - PDF)

Skoða

latviešu (LV) (305.14 KB - PDF)

Skoða

lietuvių (LT) (299.06 KB - PDF)

Skoða

magyar (HU) (289.49 KB - PDF)

Skoða

Malti (MT) (304.2 KB - PDF)

Skoða

Nederlands (NL) (277.85 KB - PDF)

Skoða

polski (PL) (305.13 KB - PDF)

Skoða

português (PT) (278.81 KB - PDF)

Skoða

română (RO) (299.89 KB - PDF)

Skoða

slovenčina (SK) (303.57 KB - PDF)

Skoða

slovenščina (SL) (302.35 KB - PDF)

Skoða

suomi (FI) (275.1 KB - PDF)

Skoða

svenska (SV) (277.71 KB - PDF)

Skoða

Íslenska (IS) (277.37 KB - PDF)

Skoða

norsk (NO) (278.69 KB - PDF)

Skoða

Product details

Name of medicine
Ingelvac PCV FLEX
Active substance
porcine circovirus type 2 ORF2 protein
International non-proprietary name (INN) or common name
porcine circovirus vaccine (inactivated)
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) code
QI09AA07

Pharmacotherapeutic group

Immunologicals for suidae

Therapeutic indication

For active immunisation of pigs with no PCV2 maternally derived antibodies from the age of 2 weeks against porcine circovirus type 2 (PCV2)

Authorisation details

EMA product number
EMEA/V/C/004645
Marketing authorisation holder
Boehringer Ingelheim Vetmedica GmbH

Binger Strasse 173
55216 Ingelheim am Rhein
Germany

Opinion adopted
16/03/2017
Marketing authorisation issued
24/05/2017
Revision
2

Assessment history

This page was last updated on

Share this page